As shown in Figure 5A–D, mRNA levels of PYGM and TNNC2 were significantly down-regulated in a majority of cancer types and a multiple of independent analyses on HNSCC illustrated the down-regulation of PYGM and TNNC2 in tumor samples. This evidence concerns the gene PYGM and neoplasm.